Called as a defense witness, Humana CEO Bruce Broussard told the judge overseeing the trial that he and Aetna CEO Mark Bertolini “almost finished each other’s sentences” when they first met. Mr. Broussard said the two executives share a “passion” for making a difference in the insurance industry and the companies have “complementary capabilities.”
The testimony came after the DOJ rested its case on day seven of the antitrust trial in Washington, D.C., according to the report. The DOJ argued the deal would reduce competition in 21 states where seniors are insured by Medicare Advantage plans. Hartford, Conn.-based Aetna and Louisville, Ky.-based Humana refute their Medicare Advantage plans compete in a different market than traditional Medicare.
More articles on payer issues:
Anthem BCBS, Colts team up to encourage child wellness exams
Anthem BCBS adds Medicare plans in Indiana
WakeMed to decline participation in BCBS’ exchange plan, leaving UNC Health Care as sole provider
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
